Viking (VKTX) to Report Q1 Earnings: What's in the Cards?
Should iShares Morningstar Small-Cap ETF (ISCB) Be on Your Investing Radar?
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
Sarepta Therapeutics' (NASDAQ:SRPT) growing losses don't faze investors as the stock increases 3.6% this past week
Should iShares Morningstar Small-Cap Growth ETF (ISCG) Be on Your Investing Radar?
US FDA approves Italfarmaco's drug for Duchenne muscle-wasting disorder
Director Wigzell Hans Lennart Rudolf Sells 15,000 Shares of Sarepta Therapeutics Inc (SRPT)
Director Stephen Mayo Sells 3,135 Shares of Sarepta Therapeutics Inc (SRPT)
REGENXBIO (RGNX) Soars 15% on Interim Data From DMD Study
Morgan Stanley says M&A will rebound and these stocks have an 'elevated likelihood' of a takeover
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
Sarepta Therapeutics to Present at Upcoming Investor Conferences
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.